Moleculin Biotech, Inc.
Moleculin Biotech, Inc. scores highest on Price (95) and lowest on Nitro (9). Its PosiPenta is 43.19 out of 100, around the middle of similar companies.
On the Penta Grid this week, Moleculin Biotech, Inc. is Grid #433 of 837 in the Healthcare sector in United States, and Grid #2,580 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Moleculin Biotech, Inc. | 43.19 | 95 | 48 | 9 | 34 | 30 |
| Tenon Medical, Inc. | 22.28 | 0 | 35 | 10 | 35 | 31 |
| Senti Biosciences Holdings, Inc. | 19.99 | 0 | 44 | 10 | 6 | 40 |
| Creative Medical Technology Holdings, Inc. | 40.72 | 44 | 46 | 18 | 59 | 37 |
| Niki BioSolutions, Inc. | 35.00 | 48 | 25 | 12 | 52 | 37 |
| Acurx Pharmaceuticals, Inc. | 33.57 | 43 | 36 | 12 | 55 | 22 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 0.03 |
| P/B ratio | 0.49 |
EEarnings
| Trailing EPS | ₹850.54 |
| Forward EPS | ₹-10466.00 |
NNitro
| Price | 26.56 |
| 52-week high | 1491.76 |
| 52-week low | 15.25 |
| Fall from 52-week high | 98.2% |
TTorque
| Return on equity (ROE) | -1371.64% |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | 2.00 |
| Market cap | ₹54 Cr |
| Insider holding | 6.13% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Moleculin Biotech, Inc.'s PosiPenta score?
Moleculin Biotech, Inc.'s PosiPenta is 43.19 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Moleculin Biotech, Inc. stand on the Penta Grid?
On the Penta Grid this week, Moleculin Biotech, Inc. is Grid #433 of 837 in the Healthcare sector in United States, and Grid #2,580 of 4,000 in United States.
Which PosiPenta pillar is strongest for Moleculin Biotech, Inc.?
Price (valuation), with a score of 95 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Moleculin Biotech, Inc.?
Nitro (momentum), with a score of 9 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.